P. Beris

发表

Optimized lentiviral transduction of erythroid precursors from healthy adults and patients with myelodysplastic syndromes

V. Kindler, V. Piguet, B. Chapuis, 2002, Leukemia.

Prediction of 18-month survival in patients with primary myelodysplastic syndrome. A regression model and scoring system based on the combination of chromosome findings and the Bournemouth score.

G. van Melle, A. Tobler, E. Haller, 1995, Cancer genetics and cytogenetics.

Atypical presentation of acute myeloid leukemia: cardiac myeloid sarcoma

J. Passweg, Y. Chalandon, F. Rigamonti, 2009, International journal of hematology.

Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis

L. Rubbia‐Brandt, F. Negro, A. Hadengue, 2000, Journal of medical virology.

Overview of myelodysplastic syndromes.

G. Georgiou, P. Beris, 2012, Seminars in hematology.

Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox.

C. Schumann, W. Hofmann, E. Angelucci, 2011, Leukemia research.

Molecular mechanism of hepcidin deficiency in a patient with juvenile hemochromatosis.

D. Trono, B. Mangeat, T. Matthes, 2004, Haematologica.

Identification of hemoglobin variants by top-down mass spectrometry using selected diagnostic product ions

P. Lescuyer, D. Hochstrasser, Alexander Scherl, 2015, Analytical and Bioanalytical Chemistry.

Recombinant Human Erythropoietin as Adjuvant Treatment for Autologous Blood Donation: A Prospective Study

P. Beris, B. Mermillod, P. Miescher, 1993, Vox sanguinis.

Hb Iraq‐Halabja β10 (A7) Ala→Val (GCC→GTC): A new β‐chain silent variant in a family with multiple Hb disorders

S. Deutsch, A. Frutiger, R. Offord, 1999 .

Growth-differentiation factor-15, endoglin and N-terminal pro-brain natriuretic peptide induction in athletes participating in an ultramarathon foot race

I. Papassotiriou, A. Margeli, M. Tsironi, 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Inclusion body beta-thalassemia trait in a Swiss family is caused by an abnormal hemoglobin (Geneva) with an altered and extended beta chain carboxy-terminus due to a modification in codon beta 114.

A. Kutlar, T. Huisman, P. Beris, 1988, Blood.

Prognostic Contribution of the New Immunoglobulin (Ig) Biomarkers (Freelite™ and Hevylite™) in Waldenstrom's Macroglobulinemia (WM)

M. Dimopoulos, S. Harding, M. Angelopoulou, 2012 .

Haemoglobin Tunis‐Bizerte: a new a globin 129 Leu–> Pro unstable variant with thalassaemic phenotype

K. Rose, P. Beris, R. Darbellay, 1995, British journal of haematology.

Cytogenetic analysis of 54 cases of myelodysplastic syndrome.

P. Beris, V. Parlier, P. Schmidt, 1990, Cancer genetics and cytogenetics.

Anemia in Clinical Practice: Introduction.

M. Cappellini, P. Beris, 2015, Seminars in hematology.

Brief Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5 (cid:1) -UTR of the HAMP gene

L. Rubbia‐Brandt, T. Ganz, P. Aguilar-Martinez, 2004 .

Non-immune Hemolysis: Diagnostic Considerations.

V. Picard, P. Beris, 2015, Seminars in hematology.

Nilotinib is superior to imatinib as first-line therapy of chronic myeloid leukemia: the ENESTnd study

R. Clark, G. Rosti, F. Giles, 2010, Expert review of hematology.

Hereditary hyperferritinaemia cataract syndrome: does it exist in Switzerland?

C. Pournaras, L. Vadas, K. Samii, 2000, Schweizerische medizinische Wochenschrift.

Investigation of microcytosis: a comprehensive approach

P. Beris, R. Darbellay, S. Mach‐Pascual, 1996, European journal of haematology.

Iron overload in patients with sideroblastic anaemia is not related to the presence of the haemochromatosis Cys282Tyr and His63Asp mutations

P. Fenaux, K. Samii, N. Zoumbos, 1999, British journal of haematology.

Cryptic splice site usage leading to truncated TMPRSS6 is responsible for iron refractory iron deficiency anaemia in an Italian Family

M. Neerman-Arbez, P. Beris, I. Tchou, 2011, European journal of haematology.

Role of Intravenous Iron Therapy in Anemia Management: State of the Art

A. Maniatis, P. Beris, 2006 .

Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias

S. Thein, A. Taher, G. Forni, 2011, European journal of haematology.

Isolated central nervous system relapses in primary mediastinal large B‐cell lymphoma after CHOP‐like chemotherapy with or without Rituximab

M. Dimopoulos, P. Korkolopoulou, M. Angelopoulou, 2013, Hematological oncology.

Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy

K. Samii, P. Beris, S. Mach‐Pascual, 1996, American journal of hematology.

Complete remission of pure white cell aplasia associated with thymoma, autoimmune thyroiditis and type 1 diabetes

B. Borisch, J. Dayer, C. Chizzolini, 2003, European journal of haematology.

Primary clonal myelodysplastic syndromes.

P. Beris, 1989, Seminars in hematology.

Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings.

G. van Melle, A. Tobler, E. Haller, 1994, Cancer genetics and cytogenetics.

Transfusion and Iron Overload : Where Are the Risks ?

P. Beris, 2019 .

Prediction of 18 months survival in patients with primary myelodysplastic syndrome: a regression model and scoring system based on the combination of chromosome findings and the bournemouth score

A. Tobler, G. Melle, E. Haller, 1994 .

Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome.

D. Mühlematter, M. Jotterand Bellomo, P. Beris, 1992, Cancer genetics and cytogenetics.

The usefulness of sequence analysis of amplified DNA for the identification of delta chain variants.

L. Wadsworth, T. Huisman, G. Schilirò, 1991, Hemoglobin.

Polyclonal hypergammaglobulinemia in a case of B‐cell chronic lymphocytic leukaemia: the result of IL‐2 production by the proliferating monoclonal B cells?

A. Mouzaki, T. Matthes, P. Beris, 1995, British journal of haematology.

Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5'-UTR of the HAMP gene.

L. Rubbia‐Brandt, T. Ganz, P. Aguilar-Martinez, 2004, Blood.

Our Current Knowledge of Iron Metabolism and Related Disorders

P. Beris, I. Tchou, 2009 .

Epigenetics in hematology: introduction.

P. Beris, 2013, Seminars in hematology.

Hb Q‐Thailand‐Hb H disease in a chinese living in Geneva, Switzerland: Characterization of the variant and identification of the two α‐thalassemic chromosomes

A. Kutlar, T. Huisman, P. Beris, 1987, American journal of hematology.

Different pathophysiological mechanisms of intramitochondrial iron accumulation in acquired and congenital sideroblastic anemia caused by mitochondrial DNA deletion

P. Rustin, T. Matthes, P. Beris, 2006, European journal of haematology.

Adrenocortical responsiveness after discontinuous corticosteroid therapy

P. Beris, A. Riondel, P. Miescher, 1986, Klinische Wochenschrift.

Immunosuppressive therapy in the treatment of autoimmune diseases

P. Beris, P. Miescher, 2005, Springer Seminars in Immunopathology.

Perisurgical Intravenous Iron Therapy

P. Beris, 1999 .

Recombinant human erythropoietin as adjuvant treatment for autologous blood donation in elective surgery with large blood needs (> or=5 units): a randomized study

P. Hoffmeyer, P. Beris, B. Mermillod, 1997, Transfusion.

Benefit of Prestorage Leukocyte Depletion of Single–Donor Platelet Concentrates

P. Roux‐Lombard, J. Dayer, B. Chapuis, 1999, Vox Sanguinis.

Prenatal diagnosis of thalassemia and hemoglobinopathies in Switzerland

P. Beris, A. Hochmann, P. Beris, 1991, European Journal of Haematology.

Recombinant Human Erythropoietin as Adjuvant Treatment for Autologous Blood Donation

P. Beris, B. Mermillod, P. Miescher, 1993 .

Black β‐thalassemia homozygotes with specific sequence variations in the 5′ hypersensitive site‐2 of the locus control region have high levels of fetal hemoglobin

T. Huisman, A. Dimovski, P. Beris, 1992, American journal of hematology.

Haplotypes and α globin gene analyses in sickle cell anaemia patients from Kenya

T. Ogada, P. Beris, Y. Hattori, 1987 .

Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set

J. Cazenave, J. Hastka, Lily Lin, 2005, Transfusion.

Severe inclusion body β‐thalassaemia with haemolysis in a patient double heterozygous for β°‐thalassaemia and quadruplicated α‐globin gene arrangement of the anti‐4.2 type

S. Deutsch, A. Tobler, G. Gabbiani, 1999 .

Hypothesis for generation of the unstable Hb Bucuresti (beta 42 Phe-->Leu) mutation.

J. Humbert, E. Roosnek, M. von Planta, 2001, The hematology journal : the official journal of the European Haematology Association.

De novo initiation codon mutation (ATG→ACG) of the β‐globin gene causing β‐thalassemia in a swiss family

D. Speiser, P. Beris, V. Kirchner, 1993 .

Haematologic data, iron parameters and molecular findings in two new cases of iron‐refractory iron deficiency anaemia

D. Swinkels, M. Neerman-Arbez, P. Beris, 2009, European journal of haematology.

MACROSCOPIC HEMATURIA IN A HEMOGLOBIN‐S HETEROZYGOTE WITH A CONCOMITANT CHROMOSOME WITH TRIPLE ALPHA LOCI: A POSSIBLE PATHOPHYSIOLOGIC MECHANISM

P. Dietrich, P. Beris, B. Ody, 1989, European journal of haematology.

Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome.

S. Antonarakis, S. Deutsch, T. Schwede, 2003, Blood.

The D 1424 N MYH 9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly / Fechtner syndrome

S. Antonarakis, S. Deutsch, T. Schwede, 2003 .

for the phenotypes in May-Hegglin anomaly / Fechtner syndrome mutation results in an unstable protein responsible MYH 9 Asp

S. Antonarakis, S. Deutsch, T. Schwede, 2003 .

Immunohistochemical expression and prognostic significance of CCND3, MCM2 and MCM7 in Hodgkin lymhoma.

P. Korkolopoulou, M. Angelopoulou, G. Pangalis, 2011, Anticancer research.

Zinc-induced copper deficiency in Wilson disease

P. Burkhard, P. Martin, P. Beris, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Trisomy 8 detection in granulomonocytic, erythrocytic and megakaryocytic lineages by chromosomal in situ suppression hybridization in a case of refractory anaemia with ringed sideroblasts complicating the course of paroxysmal nocturnal haemoglobinuria

S. Knuutila, M. Tiainen, P. Beris, 1992, British journal of haematology.

Primary acquired myelodysplastic syndromes.

P. Beris, P. Miescher, 1988, Ergebnisse der inneren Medizin und Kinderheilkunde.

50 Years of Seminars in Hematology

N. Young, P. Beris, 2013 .

Translocation 2;11 and other significant chromosome changes in acute monoblastic leukemia (M5) with clonal evolution: sequential clinical and cytogenetic studies.

C. Werner‐Favre, P. Beris, C. Cabrol, 1985, Cancer genetics and cytogenetics.

Thalidomide in patients with advanced multiple myeloma.

B. Grosbois, I. Yakoub-Agha, S. Leyvraz, 2000, The hematology journal : the official journal of the European Haematology Association.

Blood transfusion requirements in otolaryngology--head and neck surgery.

P. Dulguerov, E. Tassonyi, P. Beris, 1998, Acta oto-laryngologica.

Polyclonal hypergammaglobulinaemia with hyperviscosity syndrome

F. Amati, G. Canellini, P. Beris, 2002, British journal of haematology.

Acquired and transient RBC CD55 deficiency (Inab phenotype) and anti‐IFC

G. Daniels, J. Poole, F. Boehlen, 2002, Transfusion.

Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines

O. Habler, M. Szpalski, D. Fergusson, 2011, British journal of anaesthesia.

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care.

M. Dimopoulos, M. Angelopoulou, G. Pangalis, 2012, The oncologist.

Adoptive immunotherapy for recurrent CML after BMT.

B. Chapuis, M. Jeannet, E. Roosnek, 1993, Bone marrow transplantation.

Benefit of Prestorage Leukocyte Depletion of Single‐Donor Platelet Concentrates

P. Roux‐Lombard, J. Dayer, B. Chapuis, 1999, Vox sanguinis.

Infection‐induced transient remission and increase in the platelet count in idiopathic thrombocytopenic purpura

M. Umeda, P. Beris, M. Katoh, 1995 .

Parovirus B19-induced red cell aplasia in solid-organ transplant recipients: Two case reports and review of the literature

T. Rochat, K. Samii, P. Beris, 1997 .

Parvovirus [correction of Parovirus] B19-induced red cell aplasia in solid-organ transplant recipients. Two case reports and review of the literature.

T. Rochat, K. Samii, P. Beris, 1997, Hematology and cell therapy.

[Unusual initial manifestation in a case of refractory anemia with excess of blasts].

P. Beris, V. Parlier, M. Jotterand-Bellomo, 1991, Schweizerische medizinische Wochenschrift.

Etoposide and secondary haematological malignancies: coincidence or causality?

G. Zulian, M. Jotterand Bellomo, P. Beris, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Myelodysplasia in a patient with pre‐existing paroxysmal nocturnal haemoglobinuria: a clonal disease originating from within a clonal disease

L. Luzzatto, D. Swirsky, M. Bessler, 1994, British journal of haematology.

Autoimmune hemolytic anemia and/or thrombocytopenia associated with lupus parameters.

P. Beris, H. Favre, P. Miescher, 1992, Seminars in hematology.

Malignant histiocytosis in the leukaemic stage: a new entity (M5c-AML) in the FAB classification?

P. Roux‐Lombard, J. Dayer, B. Chapuis, 1994, Leukemia.

Spurious extreme reticulocytosis with an automated reticulocyte analyzer.

P. Beris, F. Laurencet, T. Martínez, 1997, The New England journal of medicine.

Pseudoreticulocytosis in a case of myelodysplastic syndrome with translocation t(1;14) (q42;q32).

J. Frossard, P. Beris, C. Cabrol, 1995, Seminars in hematology (Print).

Efficacy and Safety of 1 Year’s Treatment with Deferasirox (Exjade®): Assessment of Regularly Transfused Patients with Diamond-Blackfan Anemia Enrolled in the EPIC Study.

M. Cappellini, A. Taher, G. Forni, 2008 .

Severe inclusion body beta-thalassaemia with haemolysis in a patient double heterozygous for beta(0)-thalassaemia and quadruplicated alpha-globin gene arrangement of the anti-4.2 type.

S. Deutsch, A. Tobler, G. Gabbiani, 1999, British journal of haematology.

Introduction: management of thalassemia.

P. Beris, 1995, Seminars in hematology.

Association of thrombotic thrombocytopenic purpura and human immunodeficiency virus infection.

P. Beris, C. Reynard, V. Dunand, 1990, Nouvelle revue francaise d'hematologie.

Eleven cases of neoplastic microangiopathy.

P. Beris, A. Hügli, 1989, Nouvelle revue francaise d'hematologie.

Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring‐sideroblasts

M. Docquier, O. Schaad, P. Descombes, 2009, British journal of haematology.

Increased apoptosis in acquired sideroblastic anaemia

T. Matthes, K. Samii, P. Beris, 2000, British journal of haematology.

Perioperative anaemia management: consensus statement on the role of intravenous iron.

P. Linden, D. Thomas, J. García-Erce, 2008, British journal of anaesthesia.

Epoetin alfa as an adjuvant to autologous blood donation.

P. Beris, 1996, Seminars in hematology.

Lentiviral PU.1 overexpression restores differentiation in myeloid leukemic blasts

S. Durual, V. Piguet, T. Matthes, 2007, Leukemia.

Haplotypes and alpha globin gene analyses in sickle cell anaemia patients from Kenya.

A. Kutlar, T. Ogada, T. Huisman, 1987, British journal of haematology.

Disseminated toxoplasmosis in a severely immunodeficient patient: Demonstration of cysts in bone marrow smears

G. Zulian, C. Helg, P. Beris, 1991, American journal of hematology.

Compassionate Use of Midostaurin in Myeloid and Lymphoid Neoplasia with FGFR1 Abnormality

K. Samii, P. Beris, M. Nagy, 2014 .

Primary acquired sideroblastic and primary acquired refractory anemia.

P. Beris, P. Miescher, B. J. Graf, 1983, Seminars in hematology.

Prevention of beta-thalassemia major and Hb Bart's hydrops fetalis syndrome.

P. Extermann, P. Beris, R. Darbellay, 1995, Seminars in hematology.

gene HAMP-UTR of the ′ mutation in the 5 Severe hemochromatosis in a Portuguese family associated with a new

T. Ganz, Laura, P. Aguilar-Martinez, 2004 .

The use of iron to increase red cell mass.

P. Beris, 2003, Canadian Journal of Anaesthesia-journal Canadien D Anesthesie.

Perioperative anaemia management: consensus statement on the role of intravenous iron.

P. Linden, D. Thomas, J. García-Erce, 2008, British journal of anaesthesia.

[Screening for alpha-thalassemia using DNA analysis].

P. Beris, A. Hochmann, P. Miescher, 1988, Schweizerische medizinische Wochenschrift.

Translocation t(3;5) in ANLL.

C. Werner‐Favre, P. Beris, E. Engel, 1985, Cancer genetics and cytogenetics.